Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen.
With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.
Other Latest News
- Philippine Franchise Association Launches First-Ever Visayas Franchise Conference 2026 – Igniting Growth: Visayas and Beyond Asian Journal Share Post Viber icon Viber Email Cebu has always been considered a major business hub, especially in the VisMin area. Still, in recent years, its role has shifted from a regional hub to a genuine launchpad for retail concepts, food brands, and service …
- UnitedHealth Pulls Back Post 52-Week High: Healthcare ETFs to Watch Nasdaq Shares of UnitedHealth Group Incorporated UNH touched a new 52-week high on July 16, following its upbeat second-quarter release, before experiencing a modest pullback in the following days. The stock has lost 1.7% since July 17. This sell-off for …
- Showbiz backing for Britain: Cumberbatch and Co are right to raise the alarm over Warner Bros takeover, says ALEX BRUMMER Daily Mail Normally, political interventions by showbiz luvvies can be safely ignored. An op-ed in the Guardian by actors Alan Cumming, Benedict Cumberbatch and Benedict Wong opposing the $110billion takeover of Warner Bros by Paramount Skydance is an exception. The …
- Dupilumab improves height, bone density for children with eczema Healio News Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: After 16 weeks of receiving dupilumab, 31.3% …
- Speak up, Baltimore – weigh in on use of opioid settlement funds at town hall Baltimore Fishbowl - Maryland Maryland’s Office of Overdose Response invites the public to a one-hour virtual town hall to explore the best ways to use funds from the state’s prescription opioid settlements. The meeting takes place on Tuesday, Aug. 4 at 5:30 p.m. This is one of five …
- Sensex jumps 750 points, Nifty 50 ends a shade below 24,000; what drove the stock market today? Mint The Indian stock market enjoyed healthy across-segment buying interest on Monday, 27 July, with the benchmarks jumping 1% each, snapping their five-day losing streak. The 30-share pack Sensex jumped 776 points, or 1.02%, to end at 76,835.78, while the NSE …
- Havas wins a big pitch but drops 1% of total revenue in another AdNews Credit: Bruno Nascimento via Unsplash Havas, claiming a healthy pipeline of new business for the rest of 2026, says the media account for shoe and clothing company Skechers will be a top 20 account. The multi-regional client, landed via the Horizon Media …
- Registry Data Produce Insights About Pediatric Vitiligo Care Medscape MINNEAPOLIS — The first data from a retrospective cohort registry that evaluated disease manifestations, comorbidities, and treatments in 351 children with vitiligo suggest that responses to common therapies used alone or in combination differ in head and …
- Coding and Marking Equipment Market to Reach USD 8.25 Billion by 2035 at 6.2% CAGR EIN Presswire The global Coding and Marking Equipment Market reached an estimated USD 4.52 billion in 2025 and is projected to grow from USD 4.80 billion in 2026 NEW YORK, NY, UNITED STATES, July 27, 2026 /EINPresswire.com/ -- The global Coding and Marking …
- Centrifugal Blower Market to Reach USD 7.99 Billion by 2035 at 5.2% CAGR EIN Presswire The global Centrifugal Blower Market reached an estimated USD 4.82 billion in 2025 and is projected to grow from USD 5.07 billion in 2026 NEW YORK, NY, UNITED STATES, July 27, 2026 /EINPresswire.com/ -- The global Centrifugal Blower Market …
- Forte Biosciences agrees to $2.2 billion buyout The Business Journals Dallas-based Forte Biosciences is getting acquired by a Dutch pharma giant for $2.2 billion, while Lincoln Property Co. has raised $400 million and a billionaire's family office has done another RIA deal. Get the latest M&A and funding news in …
- InnoCare's Fadeucravacitinib Hits Phase III Goal In Psoriasis Trial RTTNews InnoCare Pharma (INCPF) announced that its novel TYK2 inhibitor, Fadeucravacitinib, achieved the primary endpoint in a registrational Phase III trial in patients with moderate-to-severe plaque psoriasis. Psoriasis is a chronic, immune-mediated skin disease …
- Coffee Break: Dem Establishment Resorts to Racial Divide & Conquer in Michigan naked capitalism Having destroyed Graham Platner’s candidacy in Maine, the AIPAC-funded Democratic establishment has turned its full attentions to Michigan where it hopes to use Black voters to stop anti-war candidate Dr. Abdul El-Sayed in favor of U.S. Rep. Haley Stevens …
- State to hold town halls on opioid settlement funds The Dundalk Eagle - Maryland Maryland's Office of Overdose Response will host a virtual town hall series focused on using prescription opioid settlement funds, the office announced Monday in a news release. Residents of the state are encouraged to share their ideas for how …
- Chula Licenses Indigenous Thai Probiotic Technology to Greater Pharma for Commercialization Newswise Newswise — Chulalongkorn University, through the CU Innovation Hub, has signed a licensing agreement with Greater Pharma Manufacturing Co., Ltd. to transfer probiotic technology developed from indigenous Thai microbial strains. The technology will be …
- NJ AI Hub marks first anniversary with inaugural startup cohort The Daily Princetonian - New Jersey A year after the New Jersey Artificial Intelligence Hub’s launch, the first cohort of startups has begun its AI Accelerator program. The AI Hub is a collaborative initiative between Princeton University, the State of New Jersey, Microsoft, and CoreWeave, …
- Entera Bio raises $275m for Phase III osteoporosis drug trial Globes Israeli drug development company Entera Bio (Nasdaq: ENTX) has announced a $275 million private placement. Prior to the announcement the company had a market cap of $101 million, so that the investment represents a major change in the company’s situation …
- Zealand Pharma - Transactions related to share buy-back program (week 30, 2026) EIN Presswire Company announcement No. 35 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 30, 2026) Copenhagen, Denmark, July 27, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. …
- Otsuka’s ADHD approval opens up new drug class with $615M opportunity BioSpace The FDA has greenlit Otsuka Pharmaceutical’s daily pill centanafadine for patients with attention-deficit hyperactivity disorder, opening up a new treatment class for the indication. With its approval, Simtriyo is the first norepinephrine, dopamine, …
- AstraZeneca boss urges western drugmakers to move at ‘Chinese speed’ The Guardian AstraZeneca must operate at “Chinese speed” to ensure it doesn’t suffer the fate of the western automotive industry by losing out to more innovative rivals, the drug company’s boss has said. The FTSE 100 company is watching the rise of China’s …
- Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome EIN Presswire PHILADELPHIA, July 27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic …
- Sensex, Nifty snap five-session losing run; investors add Rs 5.1 lakh crore in wealth Business Today Among the top Sensex gainers were Infosys Ltd, Bajaj Finance Ltd, ICICI Bank Ltd, Mahindra & Mahindra Ltd (M&M), InterGlobe Aviation Ltd (IndiGo's parent), Tata Consultancy Services Ltd (TCS), Sun Pharmaceutical Industries Ltd and Asian Paints …
- Glass House Brands Retains Former DEA Compliance Executive to Advise on Interstate Commerce and Export Opportunities EIN Presswire LONG BEACH, Calif. and TORONTO, July 27, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (NYSE: GLAS) today announced that the Company has retained Matt Murphy, as an advisor on DEA …
- Outlook Therapeutics wins FDA approval for Lytenava in wet AMD Pharmaceutical Technology Following years of regulatory setbacks that saw multiple rejections, Outlook Therapeutics has secured US Food and Drug Administration (FDA) approval for eye disease drug Lytenava (bevacizumab). Outlook’s Lytenava is approved for treatment of neovascular …
- AstraZeneca execs ‘very confident’ in homegrown ADC pipeline despite scrapping 2 candidates Fierce Biotech AstraZeneca executives told Fierce they are “very confident” in the pharma’s in-house pipeline of antibody-drug conjugates (ADCs) despite scrapping two candidates that underperformed in the clinic. They included an EGFR-cMET TOP1i ADC called tilatamig …
- Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026 EIN Presswire BERKELEY HEIGHTS, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial-stage biotechnology company, today announced that it will host a conference call and …
- 5 Stocks That Created Fortunes: CMPS +327%, ARWR +222%, CGON +148%, DRTS +182%, ELMD +86% RTTNews "If you aren't willing to own a stock for 10 years, don't even think about owning it for 10 minutes." - Warren Buffett. The Oracle of Omaha's timeless advice reminds us that patience is one of the key principles of investing. The …
- Stock Market Today: Sensex Jumps 776 Points, Nifty Reclaims 23,900 As Markets End 5-Day Losing Streak Latestly Stock Market Today | Representative Image | (Photo Credits: File Photo) Mumbai, July 27: Indian benchmark equity indices snapped their five-session losing streak on Monday, buoyed by a sharp decline in crude oil prices after the United States and Iran …
- Can ‘Pre-Bunking’ Cure the Health Misinformation Infodemic? Medscape Mona Amin, DO, was a resident at Albany Medical Center in Albany, New York, in 2014 when she got her first glimpse at the toll misinformation can take. A distraught mother appeared in the emergency department with a listless and bruised baby. At first, …
- Healthcare sector: Bullish on HCG, Thyrocare and FDC shares, says InCred AMC CIO Business Today InCred Asset Management’s healthcare strategy is leaning hardest into Healthcare Global (HCG), with CIO Aditya Khemka making it clear that portfolio weight—not short-term price action—is the clearest signal of conviction. Even after a muted six-month run …
- Swiss Market Index Rises as US-Iran Pause Lifts Sentiment, Defensive Pharma Giants Anchor Gains Monday International Business Times - Australia ZURICH — Switzerland's benchmark Swiss Market Index climbed Monday, joining a broader rally across European markets after the United States and Iran refrained from further military strikes over the weekend, easing investor concerns and sending oil …
- Tatva Chintan: New Products, New Capacity, New Growth Moneylife India Tatva Chintan Pharma Chem Limited (Tatva Chintan) is a specialty chemicals manufacturer with operations across four business segments: phase transfer catalysts (PTC), structure directing agents... Premium Content You can either buy this Article as a SINGLE …
- Alnylam Pharma Q2 2026 Earnings Preview: Can It Record Revenue Growth In TTR And Rare Diseases? Nasdaq (RTTNews) - Alnylam Pharmaceuticals, Inc. (ALNY) is scheduled to report second-quarter 2026 results on Thursday, July 30, 2026, with investors eyeing the commercial growth of its product line focused on TTR (transthyretin) and rare diseases, including …
- Why Is Stock Market Rising Today? Sensex Jumps Over 500 Points, Nifty Nears 24,000 as IT, Banking Stocks Lead Rally News X 127 Indian stock markets open new week on a strong note; gains in banking, IT and FMCG stocks lead the advance. After an up-and-down week previously, the Indian stock markets are off to a strong start to the new week, with benchmark indices climbing up …
- Tanfac, Emcure, Privi, HFCL among 8 stocks with fresh brokerage interest for upto 84% rise Business Today Select stocks including Tanfac Industries, Anthem Biosciences, Epigral, Emcure Pharmaceuticals, Privi Speciality Chemicals, Fineotex Chemical and HFCL have seen fresh interest from the various brokerage firms, who have recently initiated their coverage on …
- Laurus Labs Opening Bell Updates: Share Price Surges on Record Q1 FY27 Results Latestly Laurus Labs (NSE: LAURUSLABS) concluded Friday's session at ₹1,601.20, marking a 2.1% advance from its previous close, and hitting an intraday all-time high of ₹1,603. The pharmaceutical major is set for a robust start to the week, opening today at ₹1, …
- FDA rejects application for new oral MR imaging contrast agent Health Imaging The U.S. Food and Drug Administration recently rejected an application for a new oral contrast imaging agent, citing concerns related to radiologists reads during clinical trials. Biotechnology firm Ascelia Pharma is working to roll out Orviglance, a …
- 5 Biggest Earnings Reports to Watch This Week 24/7 Wall St. © 2003 Getty Images / Getty Images News via Getty Images Earnings season hits a crescendo the week of July 27, 2026, and the calendar reads like a macro stress test. Roughly 751 companies report Q2 results, and the mix leans heavily on the two themes …
- CII Telangana calls for stronger safety culture in pharma, chemical manufacturing United News of India More News 25 Jul 2026 | 10:53 PMHyderabad, July 25(UNI) Hyderabad recorded a 63 per cent year-on-year increase in leasing of large office spaces during the first half of 2026, with transactions exceeding 100,000 sq ft touching 4.9 million sq ft, according …
- Big pharma’s patent cliff meets a new biotech Cold War: We need to outrun China, not outlaw it Fortune Patrick Swayze, Alex Trebek, and Ruth Bader Ginsburg all died of pancreatic cancer. They were wealthy enough to afford any treatment that existed. But there simply wasn’t a drug available — at any price — that could save their lives. This is the cruelest …
- RI, China launch pharma venture to boost healthcare independence Antara This collaboration is expected to promote bioproducts, especially for high-prevalence conditions,Jakarta (ANTARA) - Coordinating Minister for Economic Affairs Airlangga Hartarto expressed optimism that a new joint venture between Indonesian and Chinese …
- Rs 656 dividend! Multibagger pharma stock to trade ex-date today; do you own it? Business Today Dividend Alert: As the Q1 earnings season gains momentum, multinational pharmaceutical player Abbott India has given investors some a major reason to cheer about, announcing two massive dividends of more than Rs 650 per share. The stock has trade ex- …
- Top stocks in news: Infy, Shadowfax, RailTel, IndiGo, Coforge, Meesho, Caliber Mining, MOFSL Business Today Indian benchmark indices ended lower on persistent selling as rising crude oil prices and heightened geopolitical tensions weighed on investor sentiment. Concerns over inflationary pressures and corporate margin risks further dampened market mood. The BSE …
- Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients The AI Journal PALMA DE MALLORCA, Spain, July 23, 2026 /PRNewswire/ — Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV …
- Air Cargo News Awards shortlist revealed Air Cargo News Air Cargo News is delighted to announce the finalists for the 42nd Air Cargo News Awards! The winners of the prestigious Air Cargo News Awards will be announced on Wednesday 21 October at the Royal Lancaster London hotel. The awards comprise 10 categories …
- Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference Rutland Herald - Vermont MARSEILLE, France--(BUSINESS WIRE)--Jul 23, 2026-- Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced …
- Stocks fall, pharma firms fret. Indian drug manufacturers sweat over Trump’s 100% levy on generics The Print US President Donald Trump’s plan to impose steep tariffs on generic medicines has unsettled Indian drugmakers and put the spotlight on their strategy in their biggest export market. The NSE Nifty Pharma Index slipped for a second straight session in Mumbai …
- Pharma stocks: Sun Pharma, Biocon, Dr Reddy's, Torrent Pharma shares slip after Trump's generic tariff plan Business Today Pharma stocks remained under pressure in Thursday's trade after US President Donald Trump outlined a phased tariff roadmap for imported generic medicines, raising concerns over the long-term outlook for exporters supplying the US market. In a social …
- Innate Pharma concludes enrolment in dose escalation of IPH4502 study Clinical Trials Arena French company Innate Pharma has completed patient enrolment in the dose escalation segment of the Phase I IPH4502-101 study, involving its Nectin-4 exatecan antibody-drug conjugate (ADC), IPH4502. Preliminary dataset from 76 patients is anticipated to be …
- Top stocks in news: Dr Reddys, HCL Tech, IndusInd Bank, HPCL, NTPC Green, OFSS, NAM India Business Today Indian equity benchmark indices settled on Wednesday amid rising US-Iran concerns resulting in crude oil prices rising and fall i nthe the Indian rupee. The BSE Sensex tanked 715.06 points, or 0.92 per cent, to close at 76,755.05, while NSE's Nifty50 …